{
    "clinical_study": {
        "@rank": "58529", 
        "arm_group": {
            "arm_group_label": "Renal Function Observation"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to monitor the renal function of patients who have an\n      antibiotic laden spacer in place to treat an infected hip or knee arthroplasty."
        }, 
        "brief_title": "Assessing Renal Function in Patients With an Antibiotic Laden Spacer", 
        "condition": "Infected Total Hip or Knee Arthroplasty", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. All patients undergoing a hip or knee resection arthroplasty by the primary\n             investigator\n\n          2. Ages 18+\n\n          3. Ability to adhere to follow up schedule\n\n        Exclusion Criteria:\n\n          1. Unable to give informed consent\n\n          2. Age <18\n\n          3. Previous history of infected Total Knee Arthroplasty or Total Hip Arthroplasty\n\n          4. History of renal failure or impaired renal function\n\n          5. Allergies to aminoglycosides or Vancomycin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients with an infected hip or knee arthroplasty scheduled to undergo a 2-stage\n        resection surgery"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01683734", 
            "org_study_id": "Nephro11-021-1"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 9, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "RUSH University Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winfield", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60190"
                    }, 
                    "name": "Central DuPage Hospital"
                }, 
                "investigator": {
                    "last_name": "Scott Sporer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Nephrotoxicity Following 2-Stage Exchange With Associated Antibiotic Laden Spacer in Patients With Infected Total Hip/Knee Arthroplasty", 
        "overall_contact": {
            "email": "Stefanie.Miller@CadenceHealth.org", 
            "last_name": "Stefanie Miller, BS", 
            "phone": "630-933-6254"
        }, 
        "overall_contact_backup": {
            "email": "Judy.Guerreiro@CadenceHealth.org", 
            "last_name": "Judy Guerreiro, RN", 
            "phone": "630-933-2941"
        }, 
        "overall_official": {
            "affiliation": "RUSH University Medical Center; Central DuPage Hospital", 
            "last_name": "Scott Sporer, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Development of acute renal insufficiency or acute renal failure measured by changes in laboratory values assessing renal function", 
            "safety_issue": "Yes", 
            "time_frame": "subjects will be followed during the time the antibiotic spacer is in place which is approximately 8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01683734"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Central DuPage Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Central DuPage Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}